JPM vs SWKH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
SWKH exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9, indicating poor financial health. While the company maintains an extraordinary liquidity position (Current Ratio of 54.55) and low leverage (Debt/Equity 0.14), these are overshadowed by a crashing top and bottom line, with YoY revenue growth at -27.80% and a recent Q/Q EPS collapse of -369.5%. The stock trades at a discount to book value (P/B 0.82), but the lack of growth and negative profit margins suggest a value trap rather than a value opportunity.
Compare Another Pair
Related Comparisons
JPM vs SWKH: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and SWK Holdings Corp (SWKH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.